KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Short term Debt (2016 - 2026)

Eli Lilly filings provide 18 years of Short term Debt readings, the most recent being $4.0 billion for Q1 2026.

  • On a quarterly basis, Short term Debt changed 0.41% to $4.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.0 billion, a 0.41% change, with the full-year FY2025 number at $1.6 billion, down 68.05% from a year prior.
  • Short term Debt hit $4.0 billion in Q1 2026 for Eli Lilly, up from $1.6 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.9 billion in Q4 2023 to a low of $3.1 million in Q1 2023.
  • Median Short term Debt over the past 5 years was $2.1 billion (2024), compared with a mean of $2.8 billion.
  • Biggest five-year swings in Short term Debt: plummeted 99.77% in 2023 and later skyrocketed 53174.19% in 2024.
  • Eli Lilly's Short term Debt stood at $1.5 billion in 2022, then skyrocketed by 359.96% to $6.9 billion in 2023, then dropped by 25.89% to $5.1 billion in 2024, then tumbled by 68.05% to $1.6 billion in 2025, then surged by 144.65% to $4.0 billion in 2026.
  • The last three reported values for Short term Debt were $4.0 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025) per Business Quant data.